Indegene Share Price

    NSE
    0.00
    0.00 (0.00%)
    INDGN
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Indegene Stock Performance

    1W Return2.03
    1Y Return-1.07
    Today's Low568.55
    Prev. Close576.30
    Mkt Cap (Cr.)13,813.61
    1M Return-1.88
    3Y Return0.00
    52-Week High736.3
    Open578.40
    PE Ratio77.18
    6M Return-11.67
    Today's High580.3
    52-Week Low499
    Face Value2

    Indegene Company background

    Founded in: 1998
    Indegene Limited was incorporated as Indegene Lifesystems Private Limited at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited on November 17, 2022.The Company is a digitalfirst life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency. As a specialized company, it combine healthcare domain expertise, fitforpurpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a digital first approach for optimizing the lastmile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analytics in helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies. In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.The Company acquired Cult Health, a fullservice healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.The Company launched Invisage, an AIenabled hybrid omnichannel sales and marketing platform in 2023. The Company made a public issue of 40,766,550 Equity Shares of face value of Rs 2 each by raising funds aggregating to Rs. 1842 Crore comprising a fresh issue of 16,833,818 Equity Shares aggregating to Rs. 760 Crore and 23,932,732 Equity Shares aggregating to Rs 1082 Crore through Offer for Sale in May, 2024.In 2024, the Company acquired a controlling stake in Trilogy Writing Consulting GmbH, a medical writing consultancy firm. It set up a new global delivery center in Hyderabad. In FY 2025, the Company launched a new center in Hyderabad to strengthen the business operations. In Europe, it launched a new entity in Spain and a new center in London. Indegenes Europebased clients became as a strategic hub for consulting and commercialization solutions and modernize their operations with an AIfirst approach. Further, the Company acquired MJL, a UKbased specialized healthcare advertising and communications agency. It launched Cortex, a fitforpurpose Generative AI platform for the life sciences industry.

    As of , Indegene share price is ₹575.4. The stock opened at ₹578.4 and had closed at ₹576.3 the previous day. During today’s trading session, Indegene share price moved between ₹568.55 and ₹580.30, with an average price for the day of ₹574.42. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹736.30. In terms of performance, Indegene share price has declined by 11.7% over the past six months and has declined by 0.92% over the last year.

    Read More
    View details of Market Depth

    Indegene Fundamental

    Market Cap (in crs)

    13,813.61

    Face Value

    2

    Turnover (in lacs)

    1,129.27

    Key Metrics

    Qtr Change %
    0.9
    Dividend yield 1yr %
    Below industry Median
    0.3

    Indegene Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Indegene Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    755.6 Cr
    720.4 Cr
    686.8 Cr
    676.5 Cr
    673 Cr
    Indegene Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    2946.5 Cr
    2665.9 Cr
    2364.1 Cr
    1690.5 Cr
    996.92 Cr
    Indegene Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    117.6 Cr
    109.7 Cr
    91.7 Cr
    87.7 Cr
    94.8 Cr
    Indegene Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    406.7 Cr
    336.7 Cr
    266.1 Cr
    162.82 Cr
    185.88 Cr

    Indegene Result Highlights

    • Indegene Ltd reported a 8.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were down by 7.6% QoQ and - - YoY.

    • The net profit decreased 13.6% QoQ and - - YoY.

    • The earnings per share (EPS) of Indegene Ltd stood at 4.2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Indegene

    Foreign Institutions
    5.2%
    Mutual Funds
    2.6%
    Domestic Institutions
    5%
    Public
    89.8%
    Foreign Institutions
    5%
    Mutual Funds
    1.6%
    Domestic Institutions
    4%
    Public
    91%
    Foreign Institutions
    4.8%
    Mutual Funds
    1.6%
    Domestic Institutions
    3.2%
    Public
    92%
    Foreign Institutions
    3.8%
    Mutual Funds
    2.3%
    Domestic Institutions
    3.8%
    Public
    92.4%

    Indegene Technical Analysis

    Moving Averages Analysis
    0.00
    Current Price
    Bullish Moving Averages
    8
    Bearish Moving Averages
    8
    5Day EMA
    574.90
    10Day EMA
    573.40
    12Day EMA
    573.30
    20Day EMA
    574.40
    26Day EMA
    575.50
    50Day EMA
    577.20
    100Day EMA
    579.90
    200Day EMA
    585.80
    5Day SMA
    574.80
    10Day SMA
    571.30
    20Day SMA
    571.90
    30Day SMA
    577.60
    50Day SMA
    585.00
    100Day SMA
    566.90
    150Day SMA
    581.70
    200Day SMA
    601.90
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    108664 Rs
    208723 Rs
    Week Rs
    207556 Rs
    410958 Rs
    Month Rs
    204265 Rs
    397661 Rs
    574.75
    Pivot
    Resistance
    First Resistance
    580.95
    Second Resistance
    586.50
    Third Resistance
    592.70
    Support
    First Support
    569.20
    Second support
    563
    Third Support
    557.45
    Relative Strength Index
    49.85
    Money Flow Index
    49.11
    MACD
    -2.17
    MACD Signal
    -3.60
    Average True Range
    14.71
    Average Directional Index
    9.84
    Rate of Change (21)
    0.31
    Rate of Change (125)
    -10.11
    Name
    Holding Percent
    Sbi Innovative Opportunities Fund
    1.39
    Fidelity Funds - India Focus Fund
    1.75
    Smallcap World Fund, Inc
    1.19

    Indegene Latest News

    15 JUL 2025 | Tuesday

    Indegene Ltd - 544172 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    12 JUL 2025 | Saturday

    Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    11 JUL 2025 | Friday

    Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    View More

    Indegene Share Price FAQs

    Indegene share price in the past 1-year return was -1.07. The Indegene share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 736.3.

    The market cap of Indegene is Rs. 13813.61 Cr. as of 18/7/2025.

    The PE ratios of Indegene is 77.18 as of 18/7/2025.

    The PB ratios of Indegene is 7.3 as of 18/7/2025

    The Mutual Fund Shareholding in Indegene was 2.65% at the end of 18/7/2025.

    You can easily buy Indegene shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Indegene share price is ₹736.3 and ₹499 as of 18/7/2025.

    Please be aware that Indegene stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.06
    -1.20 (-1.81%)
    133.84
    -1.07 (-0.79%)
    680.25
    -1.45 (-0.21%)
    2,596.10
    -20.50 (-0.78%)
    157.39
    -1.85 (-1.16%)
    376.00
    -5.45 (-1.43%)
    162.37
    +2.47 (+1.54%)
    257.20
    -2.45 (-0.94%)
    394.75
    -9.45 (-2.34%)
    407.90
    -5.55 (-1.34%)
    Top Gainers
    266.95
    +6.35 (+2.44%)
    942.00
    +18.70 (+2.03%)
    162.37
    +2.47 (+1.54%)
    246.31
    +2.44 (+1.00%)
    2,472.20
    +23.10 (+0.94%)
    Top Losers
    1,099.30
    -60.50 (-5.22%)
    645.50
    -19.95 (-3.00%)
    394.75
    -9.45 (-2.34%)
    739.50
    -12.30 (-1.64%)
    1,901.00
    -28.90 (-1.50%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -